We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

ANTICONVULSANT DRUGS MARKET ANALYSIS

Anticonvulsant Drugs Market, by Drug Class (Barbiturates, Benzodiazepines, Aromatic allylic alcohols, Carboxamides, Triazine, AMPA receptor antagonists, Carbamate, Hydantoin, Fatty Acid Derivative, GABA analogs, Valproylamides, Others (Propionates, Oxazolidinediones, etc.)), by Route of Administration (Enteral, Parenteral), by Indication (Epilepsy, Neuropathic pain, Anxiety, Fibromyalgia, Bipolar Disorder, Others (Borderline personality disorder, etc.)), by Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

  • Published In : Jan 2023
  • Code : CMI2516
  • Pages :170
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Anticonvulsant Drugs MarketSize and Trends

Global anticonvulsant drugs market is estimated to be valued at US$ 6,757.8 million in 2022 and is expected to reach US$ 8,030.4 million by 2030, witnessing a CAGR of 2.2% over the forecast period (2022-2030).

Figure 1. Global Anticonvulsant Drugs Market Share (%), By Region, 2022

Anticonvulsant Drugs | CMI

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Request Discount
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.